Fidia S.p.A. (BIT: FDA)
Italy
· Delayed Price · Currency is EUR | Market Cap | 777.31K |
| Revenue (ttm) | 29.17M |
| Net Income (ttm) | -6.44M |
| Shares Out | 31.09M |
| EPS (ttm) | -0.44 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 558,400 |
| Average Volume | 3,351,512 |
| Open | 0.0268 |
| Previous Close | 0.0258 |
| Day's Range | 0.0242 - 0.0268 |
| 52-Week Range | 0.0242 - 0.8600 |
| Beta | 0.24 |
| RSI | 25.67 |
| Earnings Date | Mar 17, 2025 |
About Fidia
Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]
Financial Performance
Financial StatementsNews
FDA Approves Amgen's LUMAKRAS and Vectibix Combination for Metastatic Colorectal Cancer
FDA Approves Amgen's LUMAKRAS and Vectibix Combination for Metastatic Colorectal Cancer
FDA Approves AstraZeneca's Calquence (AZN) for New MCL Treatment
FDA Approves AstraZeneca's Calquence (AZN) for New MCL Treatment
Judge allows lawsuit aiming to restrict abortion pills across US to proceed
Texas judge Matthew Kacsmaryk rules attorneys general of Idaho, Kanas and Missouri can continue mifepristone case A lawsuit that aims to restrict nationwide access to abortion pills can proceed, a fed...
ZYN Nicotine Pouches Receive FDA Marketing Approval
The U.S. Food and Drug Administration (FDA) has granted marketing authorization for 20 nicotine pouch products from ZYN , a brand of nicotine products from Philip Morris International Inc (NYSE: PM)....
FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients
FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients
AstraZeneca's CALQUENCE Gains FDA Approval for Mantle Cell Lymphoma Treatment
AstraZeneca's CALQUENCE Gains FDA Approval for Mantle Cell Lymphoma Treatment
Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer
Trump already making America healthy again
The Food and Drug Administration just announced it would ban the use of Red No. 3, a dye used in thousands of food and medicinal products to provide color but that has been linked to cancer in animals...
Philip Morris International Inc. (PM) Achieves Milestone with FDA Authorization of ZYN Nicotine ...
Philip Morris International Inc. (PM) Achieves Milestone with FDA Authorization of ZYN Nicotine Pouch
US FDA officially authorises Zyn nicotine pouches for sale
The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be sold.
FDA grants tentative approval for Amneal generic of Bausch Health's Xiafan
FDA Authorizes Zyn Nicotine Pouches
Federal health officials from the FDA backed the public health benefits of nicotine pouches.
Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
ImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details
On Wednesday, ImmunityBio, Inc. (NASDAQ: IBRX) released progress in its ongoing FDA discussions regarding three areas of its clinical development pipeline in non-muscle invasive bladder cancer (NMIBC...
NGT notices to pollution regulators, FDA chief over med waste dumping
Pune: The National Green Tribunal's principal bench in New Delhi has directed notices to be issued to the Maharashtra and Central pollution control bo.
FDA will allow Zyn nicotine pouches to stay on the market
Zyn products will be allowed to stay on the market after federal health officials Thursday said the popular nicotine pouches can help adult smokers cut back or switch completely. The Food and Drug Adm...
FDA Authorizes ZYN Nicotine Pouches: A Milestone for Philip Morris International Inc (PM)
FDA Authorizes ZYN Nicotine Pouches: A Milestone for Philip Morris International Inc (PM)
FDA officially authorizes Zyn nicotine pouches for sale following health review
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.
Philip Morris' Zyn nicotine pouches land FDA marketing approval
Atara Biotherapeutics Shares Plunge 38% Following FDA Response to EBVALLO Application
Atara Biotherapeutics Shares Plunge 38% Following FDA Response to EBVALLO Application
13 food products that contain Red No. 3, the artificial dye banned by FDA over cancer risks
Now that the FDA has banned synthetic food dye Red No. 3, food and drink manufacturers are working to figure out reformulations and recipes for their products.
What Foods Will Be Impacted by FDA’s Ban on Red Dye No. 3—And What Could Replace It
Red 3 is a synthetic colored dye that’s used to give foods a vibrant red color.
Teal Health Raises $10M as they Prepare to Launch the Teal Wand™ for At-Home Cervical Cancer Screening
With $23M in funding raised to date, Teal aims to transform a critical women's health screening. SAN FRANCISCO , Jan. 16, 2025 /PRNewswire/ -- Teal Health , a women's health company on a mission to el...
What foods contain red dye No. 3, and how do you avoid them?
Red dye No. 3 must be removed from food by mid-January 2027 and excised from ingested drugs the following year after the FDA’s decision to ban it.
Atara down 46% as FDA declines to approve organ, bone marrow transplant therapy
Atara Biotherapeutics plunges 46% after FDA issues Complete Response Letter for Ebvallo. Read more here.